Roche Finance Ltd 13D/13G Filings for Tempest Therapeutics, Inc. (TPST)

Roche Finance Ltd 13D and 13G filings for Tempest Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
06:20 am
Purchase
2021-12-3113GTempest Therapeutics, Inc.
TPST
Roche Finance Ltd72,612
1.100%
72,612increase
(New Position)
Filing